Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Cougar reaches agreement with FDA under SPA for phase III clinical trial of CB-7630

April 3, 2008

DSMB supports continuation of Genta's phase III AGENDA trial of Genasense in melanoma

April 2, 2008

Acusphere licenses hydrophobic drug delivery system and AI-850 to Cephalon

April 2, 2008

NeoPharm enrolls first patients in phase II cancer trial of liposomal paclitaxel

April 1, 2008

UCB reports phase II results for CDP-791 in non-small cell lung cancer

April 1, 2008

Protectan CBLB-502 shows mitigation of hematopoietic damage post-radiation

April 1, 2008

Seattle Genetics initiates second phase I clinical trial of SGN-35 in Hodgkin's lymphoma

April 1, 2008

Positive phase III data reported for new GnRH blocker degarelix

April 1, 2008

Recent patent literature reports novel anticancer compounds

April 1, 2008

SGX reports results from two phase I clinical trials of SGX-523 in cancer

March 31, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...